Liquid Chromatography-Mass Spectrometry in Metabolomics: Identification and Quantification of MetaboA Story by MedicilonThe field of metabolomics, particularly the identification and quantification of metabolites, has been greatly expedited by advancements in liquid chromatography-mass spectrometry (LC-MS) technology.The field of metabolomics, particularly the
identification and quantification of metabolites, has been greatly expedited by
advancements in liquid chromatography-mass spectrometry (LC-MS) technology.
LC-MS combines the physical separation properties of liquid chromatography with
the mass analysis capabilities of mass spectrometry, thus rendering an
unparalleled potential for accurate profiling of metabolites in biological
samples. The power of metabolomics lies in its
ability to survey the complete set of metabolites or the metabolome in
biological systems. However, the extensive diversity of the metabolome,
characterized by wide-ranging physicochemical properties, presents a formidable
challenge for any single analytical methodology. That’s where LC-MS comes into
play. In LC-MS, liquid chromatography separates
complex biological samples into individual metabolite components, while mass
spectrometry provides exact mass measurements facilitating the identification
and quantification of each compound. Paired together, these two methodologies
enable comprehensive and high-resolution metabolomic analyses. The LC-MS workflow starts with meticulous
sample preparation, where metabolites are extracted and purified from the
biological samples. Upon successful extraction, the metabolites are resolved
using the liquid chromatography column, followed by their detection and mass
analysis through the mass spectrometer. One key advantage of LC-MS in metabolomics
is its ability to provide both molecular weight data and structural information
about metabolites, supporting accurate identification and quantification. The
integration of MS with LC can also provide the sensitivity necessary for
detecting metabolites present at very low concentrations. While data generated from LC-MS is complex,
advancements in data processing software and bioinformatics tools have made
deciphering and analyzing this information more manageable and accessible. By
visualizing and interpreting LC-MS generated data, we can get a deeper
understanding of metabolic pathways and mechanisms in various biological
systems. In conclusion, LC-MS, as an indispensable
tool in metabolomics, has opened up new avenues for exploring the wonders of
the metabolome and advancing our understanding of how biomolecules interact and
operate within biological systems. Its powerful capabilities in metabolite
separation, identification, and quantification have provided tremendous
opportunities in advancing research in various fields including biomedical,
environmental, and agricultural science. The MetID team of Medicilon is
composed of experienced scientists. We provide fast and reliable in vivo and in
vitro MetID and reactive metabolite capture services. We also support new drug
screening and domestic and oversees IND filings. Since the establishment of
MetID team, Medicilon has successfully completed multiple different types of
research projects for clients, including challenging peptide MetID research. © 2024 Medicilon |
AuthorMedicilonCambridge, MAAboutMedicilon is an integrated contract research organization (CRO), providing comprehensive one-stop new drug R&D services for pharmaceutical enterprises and scientific research institutions around the w.. more..Writing
|